Target intelligence / Profile preview

Hemagglutinin protein (H9) on Avian Influenza Virus type A subtype H9N2

Molecular classification
Viral protein, Glycoprotein, Receptor
01

Overview

Hemagglutinin (HA) is a major surface glycoprotein of the influenza A virus, including subtype H9N2. It plays a critical role in viral infectivity by mediating both the attachment of the virus to host cells and subsequent membrane fusion required for viral entry. The HA protein is also a primary determinant of host specificity and antigenicity, making it central to immune recognition and vaccine design. HA exists as a homotrimeric integral membrane glycoprotein, with each trimer composed of three identical monomers. Each monomer is initially synthesized as an inactive precursor (HA0), which must be cleaved by host proteases into two subunits: HA1 and HA2, linked by disulfide bonds. The globular head domain (mainly HA1) contains the receptor-binding site responsible for recognizing sialic acid residues on host cell surfaces. The stem region (mainly HA2) contains elements necessary for membrane fusion; at neutral pH, its N-terminal "fusion peptide" is hidden but becomes exposed under acidic conditions in endosomes to trigger fusion. In H9 hemagglutinin specifically, structural differences compared to other subtypes are observed in the interhelical loop near residue 75 of HA2. Unlike H3 subtype which has glycine at this position allowing a sharp turn into an α-helix, H9 has alternative residues resulting in a ‘taller’ turn stabilized by hydrogen bonds—this may affect overall conformation and function.

02

Biological functions

Receptor bindingMembrane fusionViral entry
03

Disease associations

Infection
04

Safety considerations

Antigenic variation leading to immune escapePotential for zoonotic transmission due to receptor binding adaptation

Beyond the preview

Go deeper on Hemagglutinin protein (H9) on Avian Influenza Virus type A subtype H9N2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein (H9) on Avian Influenza Virus type A subtype H9N2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call